Development of a therapeutic vaccine for the treatment of cocaine addiction

Drug and Alcohol Dependence

Volumn 48, Issue 3, 1997, Pages 153-158

  Fox, Barbara S ^a  

^a ImmuLogic Pharmaceutical Corporation   (United States)

Author keywords

Anti cocaine antibody; Cocaine addiction; Therapeutic vaccine

Indexed keywords

ANTIBODY; COCAINE; COCAINE VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; IMMUNIZATION; INTRAVENOUS DRUG ADMINISTRATION; MOTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RELAPSE;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; BEHAVIOR, ADDICTIVE; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; CARRIER PROTEINS; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNIZATION, PASSIVE; MICE; RATS; SELF MEDICATION; SERUM ALBUMIN, BOVINE; VACCINES;

ANIMALIA; RODENTIA;

EID: 0030736870     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(97)00121-X     Document Type: Article

References (20)

1. Bonese K.F., Wainer B.H., Fitch F.W., Rothberg R.M., Schuster C.R. Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature. 252:1974;708-710.
2. Carrera M.R.A., Ashley J.A., Parsons L.H., Wirsching P., Koob G.F., Janda K.D. Suppression of psychoactive effects of cocaine by active immunization. Nature. 378:1995;727-730.
3. Carroll F.I., Lewin A.H., Biswas J. Chemical approaches to the treatment of cocaine abuse. Pharm. News. 1:1994;11-16.
4. Fox B.S., Kantak K.M., Edwards M.A., Black K.M., Bollinger B.K., Botka A.J., French T.L., Thompson T.L., Schad V.C., Greenstein J.L., Gefter M.L., Exley M.A., Swain P.A., Briner T.J. Efficacy of a therapeutic cocaine vaccine in rodent models. Nat. Med. 2:1996;1129-1132.
5. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
6. Institute of Medicine, 1995. Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector. Washington, DC.
7. Jatlow P.J. Cocaine: analysis, pharmacokinetics and metabolic disposition. Yale J. Biol. Med. 61:1988;105-113.
8. Jeffcoat A.R., Perez-Reyes M., Hill J.M., Sadler B.M., Cook C.E. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab. Dispos. 17:1989;153-159.
9. Jindal S.P., Lutz T. Mass spectrometric studies of cocaine disposition in animals and humans using stable isotope-labeled analogues. J. Pharm. Sci. 78:1989;1009-1014.
10. Johanson C.-E., Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41:1989;3-52.
11. Kelly, R.A., Smith, T.W., 1996. Antibody therapies of drug overdose. In: Austen, K.F., Burakoff, S.J., Rosen, F.S., Strom, T.B. (Eds.), Therapeutic Immunology. Blackwell Science, Cambridge, MA, pp. 353-362.
12. Killian A., Bonese K., Rothberg R.M., Wainer B.H., Schuster C.R. Effects of passive immunization against morphine on heroin self-administration. Pharmacol. Biochem. Behav. 9:1978;347-352.
13. Kniskern, P.I., Marburg, S., Ellis, R.W., 1995. Haemophilus influenzae type b conjugate vaccines. In: Powell, M.F., Newman, M.J. (Eds.), Vaccine Design: The Subunit and Adjuvant Approach. Plenum Press, New York, pp. 673-694.
14. Miller, N.S., Gold, M.S., Millman, R.B., 1989. Cocaine: general characteristics, abuse and addiction. NY State J. Med., pp. 390-395.
15. Nutt D.J. Addiction: brain mechanisms and their treatment implications. Lancet. 347:1996;31-36.
16. Oldendorf, W.H., 1992. Some relationships between addiction and drug delivery to the brain. In: Frankenheim, J., Brown, R.M. (Eds.), Bioavailability of Drugs to the Brain and the Blood-brain Barrier. NIDA Research Monograph 120 pp. 13-25.
17. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1988;1219-1223.
18. Rothman R.B. High affinity dopamine reuptake inhibitors as potential cocaine antagonists: A strategy for drug development. Life Sci. 46:1990;PL17-PL21.
19. Stathis M., Scheffel U., Levar S.Z., Boja J.W., Carroll F.I., Kuhar M.J. Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology. 119:1995;376-384.
20. Uhl G.R., Vandenbergh D.J., Miner L.L. Drug addiction: Knockout mice and dirty drugs. Curr. Biol. 6:1996;935-936.